Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110284149A details a green electrochemical route for mesocyclic lactams, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104892472A details a novel bis-chiral sulfoxide-alkene ligand synthesis enabling high-efficiency rhodium-catalyzed asymmetric allylation for pharmaceutical intermediate manufacturing.
Patent CN115584518A reveals a metal-free electrochemical route for N-alkyl amides. Offers mild conditions, high purity, and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel synthetic route for veranamine offers cost reduction in pharma intermediate manufacturing with scalable catalytic steps and high purity specifications for global supply chains.
Novel thiophosgene-free route for enzalutamide intermediates. Enhances supply chain safety and reduces genotoxic risks for pharmaceutical manufacturing partners globally.
Patent CN112795943A details a green electrochemical method for 3,4-dibromomaleimide, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114214646B details electrochemical synthesis avoiding toxic metals. Enables cost reduction and reliable supply chain for fine chemical intermediates.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Patent CN112574108A reveals a metal-free iodine-catalyzed route for benzo[b]azepines. Offers high yield, mild conditions, and cost-effective manufacturing for pharmaceutical intermediates.
Novel one-pot synthesis of spiroisoxazolines from dihydrochalcones. High yield, mild conditions, cost-effective pharmaceutical intermediate manufacturing.
Novel asymmetric dearomatization method for chiral benzofurans with high enantioselectivity. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN113620859A discloses a transition-metal-free route for indeno-indole ketones. This method reduces purification costs and ensures high purity for API intermediates.
Novel ruthenium catalyst enables low-loading synthesis of quinoline derivatives reducing costs and improving supply chain reliability for pharmaceutical intermediates.
Patent CN115010716B reveals mild cyclization for polysubstituted pyridines. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104447739B details deuterated Palbociclib derivatives enhancing bioavailability. We offer scalable synthesis for reliable API intermediate supply chains.
Novel phosphite ester patent CN120504699A enables mild asymmetric hydrogenation. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN105017334A reveals single Λ-configuration cobalt catalysts. Enhances asymmetric synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN108947880B reveals a metal-free visible light method for thiocarbamates. Eliminate toxic phosgene, reduce costs, and ensure supply continuity with our advanced green chemistry solutions.